HRVO
Showing 1 - 5 of 5
Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion Trial in Palo Alto (nicotinic acid)
Terminated
- Central Retinal Vein Occlusion
- Branch Retinal Vein Occlusion
- nicotinic acid
-
Palo Alto, CaliforniaPalo Alto Medical Foundation Department of Ophthalmology
Oct 21, 2019
Retinal Vein Occlusion Trial in Palo Alto (Nicotinic acid, Prednisolone acetate)
Completed
- Retinal Vein Occlusion
- Nicotinic acid
- Prednisolone acetate
-
Palo Alto, CaliforniaPalo Alto Medical Foundation Department of Ophthalmology
Dec 18, 2018
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions Trial in Houston, Katy, The Woodlands (0.5mg Ranibizumab, Targeted
Completed
- Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
- 0.5mg Ranibizumab
- Targeted Pan Retinal Photocoagulation
-
Houston, Texas
- +2 more
Aug 8, 2017
Retinal Vein Occlusion, Macular Edema Trial (ranibizumab, Squalamine Lactate Ophthalmic Solution, 0.2%)
Completed
- Retinal Vein Occlusion
- Macular Edema
- ranibizumab
- Squalamine Lactate Ophthalmic Solution, 0.2%
- (no location specified)
Nov 24, 2015